CCM
GWPH

Cadian Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Cadian Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-131,861
Closed -$14.9M – 31
2018
Q1 		$14.9M Buy
131,861
+33,197
+34% +$4.17M 0.8% 22
2017
Q4 		$13M Buy
98,664
+73,664
+295% +$8.66M 0.79% 22
2017
Q3 		$2.54M Buy
+25,000
New +$2.68M 0.12% 41

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cadian Capital Management's GWPH Position: Q2 2018 in Review

Cadian Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2018, closing a stake of 131,861 shares — an estimated $14.9M sold.

Cadian Capital Management first reported a position in GWPH in Q3 2017 and held it in 3 quarters. The position peaked at $14.9M in Q1 2018. 254 funds tracked by Wall St. Rank hold GWPH as of Q2 2018.

  • Cadian Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2018 after selling out during the quarter.
  • Cadian Capital Management sold 131,861 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2018, an estimated $14.9M.
  • Cadian Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2017 and held it in 3 quarters.
  • Cadian Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $14.9M in Q1 2018.
  • 254 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2018.

Based on Cadian Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.